Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia

Heart and Vessels

Volumn 25, Issue 4, 2010, Pages 288-293

  Tavridou, Anna ^a   Efthimiadis, Apostolos ^b   Efthimiadis, Ioannis ^b   Manolopoulos, Vangelis G ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Combined hyperlipidemia; Free radicals; Hypercholesterolemia; Oxidized low density lipoprotein; Simvastatin

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; FREE RADICAL; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT DURATION;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; FEMALE; FIBRINOGEN; FREE RADICALS; GREECE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; SIMVASTATIN; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 77956054903     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-009-1202-x     Document Type: Article

References (43)

1. D. Steinberg S. Parthasarathy T.E. Carew J.C. Khoo J.L. Witztum 1989 Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 915 924 10.1056/NEJM198901053200122 2648148
2. P. Holvoet A. Mertens P. Verhamme K. Bogaerts G. Beyens R. Verhaeghe D. Collen E. Muls F. Van de Werf 2001 Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Arterioscler Thromb Vasc Biol 21 844 848 10.1161/hq1201.100221 11348884
3. S. Ehara M. Ueda T. Naruko K. Haze A. Itoh M. Otsuka R. Komatsu T. Matsuo H. Itabe T. Takano Y. Tsukamoto M. Yoshiyama K. Takeuchi J. Yoshikawa A.E. Becker 2001 Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 1955 1960 11306523
4. K. Wallenfeldt B. Fagerberg J. Wikstrand J. Hulthe 2004 Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men J Intern Med 256 413 420 10.1111/j.1365-2796.2004.01402.x 15485477
5. D. Steinberg J.L. Witztum 2002 Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105 2107 2111 10.1161/01.CIR.0000014762. 06201.06 11980692
6. S. Bellosta F. Bernini N. Ferri P. Quarato M. Canavesi L. Arnaboldi R. Fumagalli R. Paoletti A. Corsini 1998 Direct vascular effects of HMG-CoA reductase inhibitors Atherosclerosis 137 Suppl S101 S109 10.1016/S0021-9150(97) 00319-5 9694549
7. R.S. Rosenson 2004 Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities Atherosclerosis 173 1 12 10.1016/S0021-9150(03)00239-9 15177118
8. J.K. Plenge T.L. Hernandez K.M. Weil P. Poirier G.K. Grunwald S.M. Marcovina R.H. Eckel 2002 Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction Circulation 106 1447 1452 10.1161/01.CIR.0000029743.68247.31 12234946
9. P.M. Ridker 2003 High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention Am J Cardiol 92 17K 22K 10.1016/S0002-9149(03)00774-4 12948872
10. A. Hognestad P. Aukrust R. Wergeland O. Stokke L. Gullestad A.G. Semb T. Holm A.K. Andreassen J.K. Kjekshus 2004 Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation Clin Cardiol 27 199 203 10.1002/clc.4960270405 15119693
11. F. Franzoni A. Quinones-Galvan F. Regoli E. Ferrannini F. Galetta 2003 A comparative study of the in vitro antioxidant activity of statins Int J Cardiol 90 317 321 10.1016/S0167-5273(02)00577-6 12957768
12. O. Hussein S. Schlezinger M. Rosenblat S. Keidar M. Aviram 1997 Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL Atherosclerosis 128 11 18 10.1016/S0021-9150(96) 05972-2 9051193
13. T. Inoue M. Hayashi K. Takayanagi S. Morooka 2002 Lipidlowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients Atherosclerosis 160 369 376 10.1016/S0021-9150(01)00585-8 11849660
14. A. Tavridou V.G. Manolopoulos 2004 Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivo Eur J Pharmacol 505 213 221 10.1016/j.ejphar.2004.10.047 15556155
15. K. Sakabe N. Fukuda K. Wakayama T. Nada H. Shinohara Y. Tamura 2004 Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia Am J Cardiol 94 497 500 10.1016/j.amjcard.2004.04.067 15325939
16. T. Vasankari M. Ahotupa J. Toikka J. Mikkola K. Irjala P. Pasanen K. Neuvonen O. Raitakari J. Viikari 2001 Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy Atherosclerosis 155 403 412 10.1016/S0021-9150(00)00573-6 11254911
17. S. Tsimikas 2008 In vivo markers of oxidative stress and therapeutic interventions Am J Cardiol 101 34D 42D 10.1016/j.amjcard.2008.02.006 18474272
18. U. Cornelli R. Terranova S. Luca M. Cornelli A. Alberti 2001 Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress J Nutr 131 3208 3211 11739867
19. R. Trotti M. Carratelli M. Barbieri 2002 Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum Panminerva Med 44 37 40 11887090
20. C. Vassalle P. Landi C. Boni G. Zucchelli 2007 Oxidative stress evaluated using an automated method for hydroperoxide estimation in patients with coronary artery disease Clin Chem Lab Med 45 367 371 10.1515/CCLM.2007.073 17378734
21. C. Vassalle C. Boni P. Di Cecco P. Landi 2006 Elevated hydroperoxide levels as a prognostic predictor of mortality in a cohort of patients with cardiovascular disease Int J Cardiol 110 415 416 10.1016/j.ijcard.2005.08.046 16293325
22. I.S. Young C. McFarlane J. McEneny 2003 Oxidative modification of triacylglycerol-rich lipoproteins Biochem Soc Trans 31 1062 1065 10.1042/BST0311062 14505480
23. R. Boizel P.Y. Benhamou B. Lardy F. Laporte T. Foulon S. Halimi 2000 Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels Diabetes Care 23 1679 1685 10.2337/diacare.23.11.1679 11092292
24. M. Graner J. Kahri T. Nakano S.J. Sarna M.S. Nieminen M. Syvanne M.R. Taskinen 2006 Impact of postprandial lipaemia on lowdensity lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease Eur J Clin Invest 36 764 770 10.1111/j.1365-2362.2006.01720.x 17032343
25. M. Hiki K. Shimada H. Ohmura T. Kiyanagi A. Kume K. Sumiyoshi K. Fukao N. Inoue H. Mokuno T. Miyazaki H. Daida 2009 Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease J Cardiol 53 108 116 10.1016/j.jjcc.2008.09.010 19167646
26. R. Lautamaki T. Ronnemaa R. Huupponen T. Lehtimaki P. Iozzo K.E. Airaksinen J. Knuuti P. Nuutila 2007 Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease Metabolism 56 881 886 10.1016/j.metabol.2007.01.018 17570246
27. P.G. Van Hoydonck E.G. Schouten E.H. Temme 2003 Reproducibility of blood markers of oxidative status and endothelial function in healthy individuals Clin Chem 49 963 965 10.1373/49.6.963 12765997
28. A. Molcanyiova A. Stancakova M. Javorsky I. Tkac 2006 Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia Pharmacol Res 54 203 207 10.1016/j.phrs.2006.04.009 16737822
29. S. Sasaki N. Kuwahara K. Kunitomo S. Harada T. Yamada A. Azuma K. Takeda M. Nakagawa 2002 Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia Am J Cardiol 89 386 389 10.1016/S0002-9149(01)02257-3 11835916
30. H. Oka S. Ikeda S. Koga Y. Miyahara S. Kohno 2008 Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases Heart Vessels 23 249 256 10.1007/s00380-008-1038-9 18649055
31. M. Tomas M. Senti F. Garcia-Faria J. Vila A. Torrents M. Covas J. Marrugat 2000 Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients Arterioscler Thromb Vasc Biol 20 2113 2119 10978257
32. A. Kontush C. Hubner B. Finckh A. Kohlschutter U. Beisiegel 1996 How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach Free Radic Res 24 135 147 10.3109/ 10715769609088009 8845914
33. A. Chait R.L. Brazg D.L. Tribble R.M. Krauss 1993 Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B Am J Med 94 350 356 10.1016/0002-9343(93)90144-E 8475928
34. H. Ohmura H. Mokuno M. Sawano C. Hatsumi Y. Mitsugi Y. Watanabe H. Daida H. Yamaguchi 2002 Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B Metabolism 51 1081 1087 10.1053/meta.2002.34695 12200749
35. S.G. Tsouli D.N. Kiortsis E.S. Lourida V. Xydis L.D. Tsironis M.I. Argyropoulou M. Elisaf A.D. Tselepis 2006 Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia J Lipid Res 47 2208 2214 10.1194/jlr.M600109-JLR200 16888320
36. M.J. Shin N. Chung J.H. Lee Y. Jang E. Park K.I. Jeon J.H. Chung B.Y. Seo 2007 Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients Int J Cardiol 118 173 177 10.1016/j.ijcard.2006. 03.089 17005272
37. E.M. Balk J. Lau L.C. Goudas H.S. Jordan B. Kupelnick L.U. Kim R.H. Karas 2003 Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review Ann Intern Med 139 670 682 14568856
38. C.J. Ge S.Z. Lu Y.D. Chen X.F. Wu S.J. Hu Y. Ji 2008 Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia Heart Vessels 23 91 95 10.1007/s00380-007-1008-7 18389332
39. M. Crisby K. Kublickiene L. Henareh S. Agewall 2009 Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease Heart Vessels 24 90 95 10.1007/s00380-008-1089-y 19337791
40. P. Holvoet T.B. Harris R.P. Tracy P. Verhamme A.B. Newman S.M. Rubin E.M. Simonsick L.H. Colbert S.B. Kritchevsky 2003 Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study Arterioscler Thromb Vasc Biol 23 1444 1448 10.1161/01.ATV.0000080379.05071.22 12791672
41. J. Hulthe B. Fagerberg 2002 Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study) Arterioscler Thromb Vasc Biol 22 1162 1167 10.1161/01.ATV.0000021150.63480.CD 12117732
42. P. Sjogren S. Basu M. Rosell A. Silveira U. de Faire B. Vessby A. Hamsten M.L. Hellenius R.M. Fisher 2005 Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome Arterioscler Thromb Vasc Biol 25 2580 2586 10.1161/01.ATV.0000190675.08857.3d 16224051
43. S.H. Choi A. Chae E. Miller M. Messig F. Ntanios A.N. DeMaria S.E. Nissen J.L. Witztum S. Tsimikas 2008 Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study J Am Coll Cardiol 52 24 32 10.1016/j.jacc.2008.02.066 18582631